1st April 2020 Product update: BioSearch Technologies
BioSearch COVID-19 Primers and Probes Kit Pass CDC Test for EUA
Biosearch Technologies, the custom primer design arm of LGC, has received approval from the CDC for its Primer and Probe Set and is allowed to be used under FDA-EUA. The 2019-nCoV CDC Probe and Primer Kit for SARS-CoV-2 were tested by the CDC and is now listed under its 'Acceptable Alternative Primer and Probe Sets' for use in the CDC RT-PCR Diagnostic Panel, which runs on Applied BioSystems 7500 Fast Dx Real-Time PCR System with SDS version 1.4 software.
The kits include FAM-BHQ probes and primers; N1, N2 and RP, mixed into a single assay per signature as required by protocols provided by the CDC. Oligos are delivered dried and shipped at ambient temperature.
Points to note:
- Product in stock ships same or next business day
- One of the most affordable commercial kits available - $0.23 per reaction
- From the inventor and source of Black Hole Quencher™ (BHQ™) technology referenced in US CDC protocols
- Proven track record supporting public health crises with the expertise to rapidly scale-up
Date Published: 1st April 2020
Source article link: View
Note: This content has been edited by a rapidmicrobiology staff writer for style and content.
MicrosensDx COVID-19 Point-of-Care Test: Safe,
SARS-CoV-2 Reference Materials, Standards and